Literature DB >> 10376977

Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.

F Burke1, P D Smith, M R Crompton, C Upton, F R Balkwill.   

Abstract

Interferon-gamma (IFN-gamma) has some anti-tumour activity in human ovarian cancer. This cytokine inhibited proliferation in three of four ovarian cancer cell lines in vitro. We then compared the action of IFN-gamma in two cell lines, one sensitive and one resistant to its growth inhibitory effects. IFN-gamma signalling appeared normal in both cell lines, with stat1 DNA binding activity detectable at 30 min. Continuous exposure to IFN-gamma for 2-3 days was necessary for an irreversible effect on cell growth and apoptosis in cells sensitive to growth inhibition. During this time there was an increase in mRNA for the CKI p21, but no alterations in mRNA levels for other members of the CKI family. Maintenance of p21 mRNA required continuous mRNA synthesis. mRNA for the transcription factor IRF-1 was also induced in growth inhibited cells with similar kinetics to those observed for p21. Maximal induction of both p21 and IRF-1 mRNA was observed after 2-3 days IFN-gamma exposure as the cells became committed to cell death. There was also a rapid increase in p21 and IRF-1 mRNA in cells resistant to the growth inhibitory effects of IFN-gamma, but this increase was not maintained. Thus, continuous interaction with the IFN-gamma receptor, together with a sustained induction of p21 and IRF-1, is associated with growth inhibitory and apoptotic effects of IFN-gamma in ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376977      PMCID: PMC2362378          DOI: 10.1038/sj.bjc.6690491

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 2.  The SOCS proteins: a new family of negative regulators of signal transduction.

Authors:  S E Nicholson; D J Hilton
Journal:  J Leukoc Biol       Date:  1998-06       Impact factor: 4.962

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

Authors:  A Elbendary; A Berchuck; P Davis; L Havrilesky; R C Bast; J D Iglehart; J R Marks
Journal:  Cell Growth Differ       Date:  1994-12

5.  Characterization and properties of nine human ovarian adenocarcinoma cell lines.

Authors:  S P Langdon; S S Lawrie; F G Hay; M M Hawkes; A McDonald; I P Hayward; D J Schol; J Hilgers; R C Leonard; J F Smyth
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

6.  Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

Authors:  E Pujade-Lauraine; J P Guastalla; N Colombo; P Devillier; E François; P Fumoleau; A Monnier; M Nooy; L Mignot; R Bugat; C Marques; M Mousseau; G Netter; F Maloisel; S Larbaoui; M Brandely
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

7.  Effects of tumor necrosis factor-alpha on antimitogenicity and cell cycle-related proteins in MCF-7 cells.

Authors:  D I Jeoung; B Tang; M Sonenberg
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

8.  Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

Authors:  Y E Chin; M Kitagawa; W C Su; Z H You; Y Iwamoto; X Y Fu
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

9.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.

Authors:  Z Fan; Y Lu; X Wu; A DeBlasio; A Koff; J Mendelsohn
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

View more
  17 in total

1.  PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.

Authors:  Christine M Fam; Stephen P Eisenberg; Sharon J Carlson; Elizabeth A Chlipala; George N Cox; Mary S Rosendahl
Journal:  J Interferon Cytokine Res       Date:  2014-05-19       Impact factor: 2.607

2.  Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1).

Authors:  Peiyuan Li; Qiang Du; Zongxian Cao; Zhong Guo; John Evankovich; Wei Yan; Ying Chang; Lifang Shao; Donna Beer Stolz; Allan Tsung; David A Geller
Journal:  Cancer Lett       Date:  2011-10-01       Impact factor: 8.679

3.  Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis.

Authors:  K M Detjen; K Farwig; M Welzel; B Wiedenmann; S Rosewicz
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

4.  IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.

Authors:  Michaele J Armstrong; Michael T Stang; Ye Liu; Jin Yan; Eva Pizzoferrato; John H Yim
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling.

Authors:  Sveta Padmanabhan; Bijaya Gaire; Yue Zou; Mohammad M Uddin; Ivana Vancurova
Journal:  Cell Signal       Date:  2022-07-09       Impact factor: 4.850

6.  Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma.

Authors:  Gregory A Watson; Pierre E Queiroz de Oliveira; Michael T Stang; Michaele J Armstrong; William E Gooding; Shih-Fan Kuan; John H Yim; Steven J Hughes
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

7.  Activated CD4+ T cells enhance radiation effect through the cooperation of interferon-gamma and TNF-alpha.

Authors:  Yixiang Wang; Soroosh Radfar; Hung T Khong
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

8.  Identifying multi-layer gene regulatory modules from multi-dimensional genomic data.

Authors:  Wenyuan Li; Shihua Zhang; Chun-Chi Liu; Xianghong Jasmine Zhou
Journal:  Bioinformatics       Date:  2012-08-03       Impact factor: 6.937

9.  rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition.

Authors:  Bohuslav Melichar; Wei Hu; Rebecca Patenia; Karolina Melicharová; Stacie T Gallardo; Ralph Freedman
Journal:  J Transl Med       Date:  2003-09-19       Impact factor: 5.531

10.  A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine.

Authors:  Michael Höpfner; Andreas P Sutter; Alexander Huether; Gudrun Ahnert-Hilger; Hans Scherübl
Journal:  BMC Cancer       Date:  2004-05-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.